Related Experiment Video
Updated: May 21, 2026

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
Executive Dysfunction in MCI: Subtype or Early Symptom
Ivar Reinvang1, Ramune Grambaite, Thomas Espeseth
1Center for the Study of Human Cognition, Department of Psychology, University of Oslo, 0316 Oslo, Norway.
Abstract:
Mild cognitive impairment (MCI) may take several forms, and amnestic MCI (aMCI) has been recognized as an early stage of Alzheimer's Disease (AD). Impairment in executive functions including attention (eMCI) may be indicative of several neurodegenerative conditions. Executive impairment is frequently found in aMCI, it is significant for prognosis, and patients with eMCI may go on to develop AD. Recent studies have found changes in white matter integrity in patients with eMCI to be more sensitive than measures of cortical atrophy. Studies of genetic high-risk groups using sensitive cognitive neuroscience paradigms indicate that changes in executive function may be a cognitive marker useful for tracking development in an AD pathophysiological process.
Insights
Executive function impairments, or executive MCI (eMCI), may signal early Alzheimer's Disease (AD). Changes in white matter integrity are sensitive markers for tracking AD progression in at-risk individuals.
Area of Science:
- Neuroscience
- Cognitive Science
- Neurology
Background:
- Mild cognitive impairment (MCI) presents diverse forms, with amnestic MCI (aMCI) often preceding Alzheimer's Disease (AD).
- Executive function impairments, termed executive MCI (eMCI), are linked to neurodegenerative conditions and can indicate future AD development.
- Executive dysfunction is a significant prognostic factor in aMCI and a potential early indicator of AD pathophysiology.
Purpose of the Study:
- To investigate the role of executive function deficits in the early detection and progression of Alzheimer's Disease.
- To evaluate the sensitivity of white matter integrity changes compared to cortical atrophy in identifying eMCI.
- To explore the utility of executive function as a cognitive marker in genetically high-risk populations for AD.
Main Methods:
- Analysis of cognitive function, focusing on executive functions and attention.
- Assessment of white matter integrity using advanced neuroimaging techniques.
- Evaluation of cortical atrophy as a comparative measure.
- Utilizing cognitive neuroscience paradigms in genetically defined high-risk groups.
Main Results:
- Executive function impairments (eMCI) are frequently observed in aMCI and are significant for prognosis.
- Changes in white matter integrity show higher sensitivity than cortical atrophy measures in detecting eMCI.
- Cognitive neuroscience studies in high-risk groups suggest executive function changes are valuable markers for AD development.
Conclusions:
- Executive function deficits, particularly in eMCI, are critical indicators in the early stages of neurodegeneration.
- White matter integrity is a more sensitive biomarker than cortical atrophy for tracking early AD-related changes.
- Executive function serves as a promising cognitive marker for monitoring AD progression, especially in at-risk populations.
Related Concept Videos
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction
Huntington Disease l: Introduction
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Role of Cerebellum and Prefrontal Cortex in Memory

